Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Clinical Trial

Case Reports

Randomized Controlled Trial

Comparative Study

Meta-Analysis

Systematic Review

Research Support, N.I.H., Intramural

Network Meta-Analysis

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2022

2020

2019

2018

2017

2016

2013

2012

2011

2009

2007

2006

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""B-Cell Activating Factor""[mesh_terms]

16 Results

Searching titles within these results

Telitacicept for Recalcitrant Cutaneous Manifestations of Systemic Lupus Erythematosus: A Case Report and Review of the Literature.

Xinyue Ma, Xiaoying Fu, Beibei Cui, Hui Lin

The Tohoku journal of experimental medicine 2022;258(3):219-223

Free Full Text

Abstract

B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets.

E Becerra, I De La Torre, M J Leandro, G Cambridge

Clinical and experimental immunology 2017;190(3):372-383

Free Full Text

Abstract

The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy.

Ladislav Senolt, Olga Kryštůfková, Hana Hulejová, Markéta Kuklová, Mária Filková, Lucie Andrés Cerezo, Jaromír Běláček, Martin Haluzík, Sárka Forejtová, Steffen Gay, Karel Pavelka, Jiří Vencovský

Cytokine 2011;55(1):116-21

Full Text

Abstract

Telitacicept: First Approval.

Sohita Dhillon

Drugs 2022;81(14):1671-1675

Full Text

Abstract

Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies.

Latha Shivakumar, Stephen Ansell

Clinical lymphoma & myeloma 2006;7(2):106-8

Full Text

Abstract

Cholecalciferol Supplementation Did Not Change Interleukin-7 and B cell-Activating Factor Levels and CD95 Expression in B lymphocytes in Patients on Dialysis: A Randomized Pilot-Controlled Trial.

José Tarcisio Giffoni de Carvalho, Marion Schneider, Lilian Cuppari, Caren Cristina Grabulosa, Miguel Cendoroglo, Maria Aparecida Dalboni

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2020;29(5):454-461

Full Text

Abstract

Effect of probiotic lozenges containing Lactobacillus reuteri on oral wound healing: a pilot study.

S Twetman, M K Keller, L Lee, T Yucel-Lindberg, A M Lynge Pedersen

Beneficial microbes 2018;9(5):691-696

Full Text

Abstract

B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.

Vassilia-Ismini Alexaki, Vassiliki Pelekanou, George Notas, Maria Venihaki, Marilena Kampa, Valérie Dessirier, Sanaa Sabour-Alaoui, Efstathios N Stathopoulos, Andreas Tsapis, Elias Castanas

Endocrinology 2012;153(2):739-49

Full Text

Abstract

The role of TNF-α superfamily members in immunopathogenesis of sepsis.

Dajana F Lendak, Dunja M Mihajlović, Aleksandra S Novakov-Mikić, Igor M Mitić, Jasmina M Boban, Snežana V Brkić

Cytokine 2019;111():125-130

Full Text

Abstract

Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis.

F Zaccardi, D R Webb, Z Z Htike, D Youssef, K Khunti, M J Davies

Diabetes, obesity & metabolism 2017;18(8):783-94

Full Text

Abstract

The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.

Mi-Ae Lyu, Lawrence H Cheung, Walter N Hittelman, John W Marks, Ricardo C T Aguiar, Michael G Rosenblum

Molecular cancer therapeutics 2007;6(2):460-70

Full Text

Abstract

Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK.

Hong-Ying Wang, Chi A Ma, Yongge Zhao, Xiying Fan, Qing Zhou, Pamela Edmonds, Gulbu Uzel, Joao Bosco Oliveira, Jordan Orange, Ashish Jain

Proceedings of the National Academy of Sciences of the United States of America 2013;110(13):5127-32

Free Full Text

Abstract

Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.

Vassilia-Ismini Alexaki, George Notas, Vassiliki Pelekanou, Marilena Kampa, Maria Valkanou, Panayiotis Theodoropoulos, Efstathios N Stathopoulos, Andreas Tsapis, Elias Castanas

Journal of immunology (Baltimore, Md. : 1950) 2009;183(9):5948-56

Full Text

Abstract

Correlation of APRIL with production of inflammatory cytokines during acute malaria in the Brazilian Amazon.

Raquel A Pinna, Adriana C Dos Santos, Daiana S Perce-da-Silva, Luciene A da Silva, Rodrigo N Rodrigues da Silva, Marcelo R Alves, Fátima Santos, Joseli de Oliveira Ferreira, Josué C Lima-Junior, Déa M Villa-Verde, Paula M De Luca, Carla E Carvalho-Pinto, Dalma M Banic

Immunity, inflammation and disease 2019;6(2):207-220

Free Full Text

Abstract

Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.

M Jasek, M Wagner, M Sobczynski, D Wolowiec, K Kuliczkowski, D Woszczyk, M Kielbinski, P Kusnierczyk, I Frydecka, L Karabon

Tissue antigens 2016;86(4):279-84

Full Text

Abstract

Results: 1 – 15 / 16

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""B-Cell Activating Factor""[mesh_terms]

Telitacicept for Recalcitrant Cutaneous Manifestations of Systemic Lupus Erythematosus: A Case Report and Review of the Literature.

B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets.

The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy.

Telitacicept: First Approval.

Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies.

Cholecalciferol Supplementation Did Not Change Interleukin-7 and B cell-Activating Factor Levels and CD95 Expression in B lymphocytes in Patients on Dialysis: A Randomized Pilot-Controlled Trial.

Effect of probiotic lozenges containing Lactobacillus reuteri on oral wound healing: a pilot study.

B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.

The role of TNF-α superfamily members in immunopathogenesis of sepsis.

Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis.

The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.

Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK.

Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.

Correlation of APRIL with production of inflammatory cytokines during acute malaria in the Brazilian Amazon.

Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.

Results for
""B-Cell Activating Factor""[mesh_terms]